Immunocore Holdings plc
IMCR
$33.98
-$0.50-1.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -808.00K | 12.97M | -30.06M | -177.00K | -10.30M |
| Total Depreciation and Amortization | 1.03M | 948.00K | 834.00K | 798.00K | 780.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.30M | 2.20M | 23.67M | -3.75M | 8.75M |
| Change in Net Operating Assets | 7.41M | -29.89M | -27.10M | -1.32M | 26.74M |
| Cash from Operations | 15.93M | -13.78M | -32.66M | -4.46M | 25.96M |
| Capital Expenditure | -786.00K | -1.78M | -2.88M | -748.00K | -414.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 6.00M | 2.00M | 6.00M | -30.00M |
| Cash from Investing | -786.00K | 4.22M | -880.00K | 5.25M | -30.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16.49M | 656.00K | 4.28M | 1.87M | 3.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.49M | 656.00K | 4.28M | 1.87M | 3.67M |
| Foreign Exchange rate Adjustments | 618.00K | -6.13M | -1.45M | 7.82M | 11.87M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.25M | -15.03M | -30.70M | 10.48M | 11.09M |